RNA-based therapeutics

Bioarchitech is a company developing multifunctional immunotherapies targeting cancer and virus-related diseases. It mines the genetic code of viruses to produce therapies that both kill cancer cells and induce immunity. Its pipeline includes BA-V151, an intravenous viral therapy based on a modified Vaccinia virus for metastatic cancer, and BA-R166, an intratumoural self-amplifying RNA immunotherapy for early-stage cancers.

Read more

immunotherapy developmentviral therapy development